539 related articles for article (PubMed ID: 28666115)
21. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
Seremet T; Koch A; Jansen Y; Schreuer M; Wilgenhof S; Del Marmol V; Liènard D; Thielemans K; Schats K; Kockx M; Van Criekinge W; Coulie PG; De Meyer T; van Baren N; Neyns B
J Transl Med; 2016 Aug; 14(1):232. PubMed ID: 27484791
[TBL] [Abstract][Full Text] [Related]
22. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
23. Tumour-specific CD4 T cells eradicate melanoma via indirect recognition of tumour-derived antigen.
Shklovskaya E; Terry AM; Guy TV; Buckley A; Bolton HA; Zhu E; Holst J; Fazekas de St. Groth B
Immunol Cell Biol; 2016 Jul; 94(6):593-603. PubMed ID: 26837456
[TBL] [Abstract][Full Text] [Related]
24. Role of IL-10 and TGF-β in melanoma.
Wiguna AP; Walden P
Exp Dermatol; 2015 Mar; 24(3):209-14. PubMed ID: 25565012
[TBL] [Abstract][Full Text] [Related]
25. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
[TBL] [Abstract][Full Text] [Related]
26. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
[TBL] [Abstract][Full Text] [Related]
27. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
28. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
29. Modulation of innate immunity in the tumor microenvironment.
Gonzalez-Gugel E; Saxena M; Bhardwaj N
Cancer Immunol Immunother; 2016 Oct; 65(10):1261-8. PubMed ID: 27344341
[TBL] [Abstract][Full Text] [Related]
30. Detection of differentially abundant cell subpopulations in scRNA-seq data.
Zhao J; Jaffe A; Li H; Lindenbaum O; Sefik E; Jackson R; Cheng X; Flavell RA; Kluger Y
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34001664
[TBL] [Abstract][Full Text] [Related]
31. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
[TBL] [Abstract][Full Text] [Related]
32. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
[TBL] [Abstract][Full Text] [Related]
33. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
Qu Y; Zhang S; Zhang Y; Feng X; Wang F
Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
[TBL] [Abstract][Full Text] [Related]
34. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas.
Vermi W; Bonecchi R; Facchetti F; Bianchi D; Sozzani S; Festa S; Berenzi A; Cella M; Colonna M
J Pathol; 2003 Jun; 200(2):255-68. PubMed ID: 12754747
[TBL] [Abstract][Full Text] [Related]
35. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
Tirosh I; Izar B; Prakadan SM; Wadsworth MH; Treacy D; Trombetta JJ; Rotem A; Rodman C; Lian C; Murphy G; Fallahi-Sichani M; Dutton-Regester K; Lin JR; Cohen O; Shah P; Lu D; Genshaft AS; Hughes TK; Ziegler CG; Kazer SW; Gaillard A; Kolb KE; Villani AC; Johannessen CM; Andreev AY; Van Allen EM; Bertagnolli M; Sorger PK; Sullivan RJ; Flaherty KT; Frederick DT; Jané-Valbuena J; Yoon CH; Rozenblatt-Rosen O; Shalek AK; Regev A; Garraway LA
Science; 2016 Apr; 352(6282):189-96. PubMed ID: 27124452
[TBL] [Abstract][Full Text] [Related]
36. ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.
Chen CF; Ruiz-Vega R; Vasudeva P; Espitia F; Krasieva TB; de Feraudy S; Tromberg BJ; Huang S; Garner CP; Wu J; Hoon DS; Ganesan AK
Cell Rep; 2017 Mar; 18(10):2331-2342. PubMed ID: 28273450
[TBL] [Abstract][Full Text] [Related]
37. Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.
Aspord C; Leccia MT; Charles J; Plumas J
Cancer Immunol Res; 2013 Dec; 1(6):402-15. PubMed ID: 24778133
[TBL] [Abstract][Full Text] [Related]
38. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
[TBL] [Abstract][Full Text] [Related]
39. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
40. Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.
Aris M; Bravo AI; Pampena MB; Blanco PA; Carri I; Koile D; Yankilevich P; Levy EM; Barrio MM; Mordoh J
Front Immunol; 2018; 9():955. PubMed ID: 29774030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
